April
Supreme Court urged to invalidate data law
A coalition of parties, including PhRMA, is asking the US Supreme Court to invalidate a state law that curtails the use of a physician's prescribing history in pharma marketing
04 Apr 2011
Omeros phase III knee surgery drug fails
A Omeros Corporation drug developed to increase mobility and reduce pain in patients who have undergone arthroscopic knee surgery has failed to meet the primary endpoints of a phase III programme
04 Apr 2011
Informal PMCPA digital guidance
The UK's Prescription Medicines Code of Practice Authority has published 'informal guidance' on digital communications and launched an e-learning module as part of an awareness week for the ABPI Code of Practice
04 Apr 2011
S-A completes takeover of Genzyme
Sanofi-aventis is to complete its takeover of Genzyme after the company announced it had finalised its exchange offer for all outstanding shares of common stock of the US-based biotech
04 Apr 2011
FDA reviewers support Optimer antibiotic
Reviewers from the US Food and Drug Administration have issued a positive memo on Optimer Pharmaceuticals' C. difficile treatment fidaxomicin ahead of an advisory committee meeting
04 Apr 2011
FDA delays social media guidance again
The US Food and Drug Administration has again delayed draft guidance on social media, citing the complicated nature of the issue and the limited time and money at its disposal
04 Apr 2011
Stephen Whitehead appointed as ABPI CEO
Stephen Whitehead will take up the role of ABPI CEO with effect from June 1, taking over from Richard Barker who steps down as director general on May 25
05 Apr 2011
GSW launches health and wellness division
GSW Worldwide has announced the launch of a new health and wellness capability called The Well @GSW. It will focus on providing marketers with expertise in consumer health
05 Apr 2011
Pfizer sells Capsugel business for $2.4bn
Pfizer has entered into an agreement to sell its hard capsule business Capsugel to Kohlberg Kravis Roberts & Co (KKR) for a cash sum of $2.375bn
05 Apr 2011
FDA refuses to file Pfizer NDA
The US Food and Drug Administration has refused to accept Pfizer's new drug application for a potential treatment for a rare, progressively fatal genetic neurodegenerative disease
05 Apr 2011